Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Flushing, Headache, Heart rate increased, Insomnia
Clinical narrative: Nausea/vomiting; Nausea/vomiting; Chills; Head ache; Flushing; Feeling hot; Red face the next day; Pretty significant pain in hip; Pretty significant pain in bone; Heart rate went up; Big, butterfly rash on her face; Hard time sleeping; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (Pretty significant pain in bone), HEART RATE INCREASED (Heart rate went up), BUTTERFLY RASH (Big, butterfly rash on her face), INSOMNIA (Hard time sleeping) and ERYTHEMA (Red face the next day) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypersensitivity reaction (NOS) (Hypersensitivity reactions). Previously administered products included for an unreported indication: Flu Vaccine (welts down arm from injection site to wrist (almost in a distribution line) following vein/or nerve gone by day 3.) in 2020. Concurrent medical conditions included Sjogren's (worsened, sores in nose, vertigo, increased pain in joints and bones, increased dryness, and dizziness), Dysautonomia (worsened, sores in nose, vertigo, increased pain in joints and bones, increased dryness, and dizziness) and Autoimmune disorder NOS (Autoimmune disease). Concomitant products included AUTOLOGOUS HUMAN CORNEAL EPITHELIAL CELLS for Dry eyes, HYDROXYCHLOROQUINE, METHOTREXATE, KETOTIFEN from an unknown date to 04-Sep-2021, ESTRADIOL, PANTOPRAZOLE, VITAMINS NOS, CICLOSPORIN (RESTASIS), HYDROXYCHLOROQUINE SULFATE (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]), NALTREXONE HYDROCHLORIDE (NALTREXON) and TOPIRAMATE for an unknown indication.    On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jul-2021, the patient experienced BONE PAIN (Pretty significant pain in bone), HEART RATE INCREASED (Heart rate went up), BUTTERFLY RASH (Big, butterfly rash on her face), INSOMNIA (Hard time sleeping) and ARTHRALGIA (Pretty significant pain in hip). On 18-Jul-2021, the patient experienced ERYTHEMA (Red face the next day). On an unknown date, the patient experienced FLUSHING (Flushing), FEELING HOT (Feeling hot), NAUSEA (Nausea/vomiting), VOMITING (Nausea/vomiting), CHILLS (Chills) and HEADACHE (Head ache). The patient was treated with KETOROLAC TROMETHAMINE (TORADOL) for Pain, at an unspecified dose and frequency; PREDNISONE at a dose of 5 days and SALINE [SODIUM CHLORIDE] (intravenous) for Adverse event, at an unspecified dose and frequency. At the time of the report, BONE PAIN (Pretty significant pain in bone), HEART RATE INCREASED (Heart rate went up), BUTTERFLY RASH (Big, butterfly rash on her face), INSOMNIA (Hard time sleeping), ERYTHEMA (Red face the next day), FLUSHING (Flushing), FEELING HOT (Feeling hot), ARTHRALGIA (Pretty significant pain in hip), NAUSEA (Nausea/vomiting), VOMITING (Nausea/vomiting), CHILLS (Chills) and HEADACHE (Head ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also included unspecified steroids   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: FU received on 13-SEP-2021 include second dose information, patient demographics updated, concomitant medications added, treatment information updated, onset date for events (bone pain, arthralgia, insomnia, butterfly rash and heart rate increased) updated, current condition Autoimmune disease and historical condition hypersensitivity reactions updated, concomitant medication information updated.